Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ethyl gallate
Cat. No.:
0225LY-1299
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Ethyl gallate inhibits the proliferation and invasion of breast cancer cells by modulating the PI3K/Akt pathway and reducing the expression of MMP-2, MMP-9, and NF-κB.
Synonym:
Nipagallin A; Phyllemblin; Gallic acid ethyl ester; 831-61-8; Ethyl 3,4,5-trihydroxybenzoate; Gallic acid ethyl ester; Phyllemblin; Ethylgallate; Nipagallin A; Progallin A; Gallic acid, ethyl ester; Benzoic acid, 3,4,5-trihydroxy-, ethyl ester; 3,4,5-Trihydroxybenzoic acid ethyl ester; Ethyl-3,4,5-trihydroxybenzoate; Ethylester kyseliny gallove
CAS No.:
831-61-8
Compound CID:
13250
Formula:
C9H10O5
Formula Weight:
198.17
Specification
Relative Density:
1.424 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ethyl gallate can be used in antioxidant research to evaluate its efficacy in scavenging free radicals and protecting against cellular damage.
Library Information
Target:
MMP; NF-κB; Akt
Receptor:
Akt; MMP-2; MMP-9; NF-κB
Pathways:
Cytoskeletal signaling; Microbiology/Virology; NF-κB; Proteases/Proteasome; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-17
Plate Location:
f6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
36 mg/mL; 181.66 mM
ALogP:
1.308
HBA_Count:
2
HBD_Count:
3
Rotatable Bond:
3
